about
Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylaseYin Yang 1 regulates the transcriptional repression of SurvivinMaking Meaningful Clinical Use of BiomarkersStable expression of small interfering RNA sensitizes TEL-PDGFbetaR to inhibition with imatinib or rapamycin.Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancerSuppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit.Early diagnostic value of survivin and its alternative splice variants in breast cancer.Cell death in response to antimetabolites directed at ribonucleotide reductase and thymidylate synthaseSurvivin is released from cancer cells via exosomes.Small RNA: can RNA interference be exploited for therapy?Exosomes Secreted from Human Cancer Cell Lines Contain Inhibitors of Apoptosis (IAP).AML sensitivity to YM155 is modulated through AKT and Mcl-1.Proteomic Profiling of Serum-Derived Exosomes from Ethnically Diverse Prostate Cancer PatientsEnhanced antitumor effect of combined gemcitabine and proton radiation in the treatment of pancreatic cancer.Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis.Enhancement of Gemcitabine sensitivity in pancreatic adenocarcinoma by novel exosome-mediated delivery of the Survivin-T34A mutant.Survivin-T34A: molecular mechanism and therapeutic potential.Clinico-pathologic relevance of Survivin splice variant expression in cancerCombination antiangiogenic therapy and radiation in head and neck cancers.Immunoseroproteomic Profiling in African American Men with Prostate Cancer: Evidence for an Autoantibody Response to Glycolysis and Plasminogen-Associated Proteins.Differential protein expression in exosomal samples taken from trauma patients.Peritoneal carcinomatosis: limits of diagnosis and the case for liquid biopsy.Therapeutic Application of Natural Medicine Monomers in Cancer Treatment.Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75.Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential.Differential effect of proIGF-II and IGF-II on resveratrol induced cell death by regulating survivin cellular localization and mitochondrial depolarization in breast cancer cells.Yin Yang 1 is a negative regulator of p53.Induction of apoptosis of human B-CLL and ALL cells by a novel retinoid and its nonretinoidal analog.Effects of combretastatin A-4 prodrug against a panel of malignant human B-lymphoid cell lines.Modulation of cIAP-1 by novel antitubulin agents when combined with bryostatin 1 results in increased apoptosis in the human early pre-B acute lymphoblastic leukemia cell line Reh.Bax:Bcl-2 ratio modulation by bryostatin 1 and novel antitubulin agents is important for susceptibility to drug induced apoptosis in the human early pre-B acute lymphoblastic leukemia cell line, Reh.Colorectal cancer screening using protected microRNAs.Racial differences in the expression of inhibitors of apoptosis (IAP) proteins in extracellular vesicles (EV) from prostate cancer patients.Evaluation of combretastatin A-4 prodrug in a non-Hodgkin's lymphoma xenograft model: preclinical efficacy.Cloning and characterization of Rhodotorula glutinis thymine hydroxylase.Peripheral Blood Cell Interactions of Cancer-Derived Exosomes Affect Immune Function.Yin Yang 1 (YY1): Regulation of Survivin and Its Role In Invasion and Metastasis.Exosomal survivin facilitates vesicle internalizationDifferential protein expression in exosomal samples taken from trauma patientsGastric Cancer Peritoneal Carcinomatosis Risk Score
P50
Q24297207-93D33CF4-B4A2-4A32-9AA3-6739FC05BF56Q33810310-F57A0878-65F2-429A-96CE-8DB35EF5E114Q33821481-13FC3E56-731F-4CE9-8C06-2186BDA8DDD4Q34327213-B9317D67-5701-44CA-A98E-5329F06E3AE0Q34455096-DBE1BF15-CF2E-4EA1-8495-C6F6A4266A61Q34629092-9EE822C5-37F8-4087-B16E-FF52DF362C3AQ35118374-8E9F987F-A64C-410F-A281-CDF978A1E601Q35161704-A584DB48-E1E8-4B37-851A-7C14FB300875Q35217196-81058A53-33B5-4FB2-B7C9-F617E7DE35F0Q35571567-E0FA32E7-C503-4D25-9112-64BEB5817552Q35975247-B41B5DD5-4843-4960-9A98-81ECB9B039C9Q35983805-D46522AF-5944-4659-B259-E261B4FF01F5Q36520462-88EFC9E7-F96C-4751-B33F-6F54D5EFF3B0Q37440160-4975B6B9-D508-4A44-8B0F-F30F84EA4F71Q37574259-C7E1627A-E682-46D1-8F57-3BC64014657EQ37593002-2ECB76FE-61C7-4161-8D6D-86A6D35D9FF8Q37834973-6253484A-5637-425D-B61A-EE2C0516E89EQ38116267-7BCDE0D1-D492-44EA-9049-048C5669FE99Q38165603-3B98D702-2B0B-4667-8130-A2EBA6762B4BQ38386585-FC430B7D-57C4-49EF-8F4E-18C5851E1FB3Q38678949-F014D24D-E668-4531-A216-CEE0E39DE47FQ39246331-768832A1-8EA2-4A03-8121-67E7444B1E64Q39438492-14317492-0102-44D8-9129-300FB2F35BC0Q39806758-E11FEA62-B756-406C-B5CD-D0B76EA8FF5FQ39871645-B3DD2FC9-3B53-4EC8-A631-BA7FDD39A629Q39998617-05C6B456-1F46-4CDF-971F-349AD0D5B233Q40542917-11C65978-5EDA-4521-9BDD-8668811BCD2DQ40701135-6FC8A253-CD2E-4017-B93D-43A1C3E934FAQ40866080-8A0CC798-A978-4262-90E3-CC494CEA705CQ40914679-F97BD3DF-3530-467B-929B-EF66204E0DE0Q40916192-850ADB38-C084-4631-9DC5-EBE40512EEACQ42109814-AD40946E-186D-4F19-86AA-9850C22CEBEBQ42370655-AFD90AF3-C28E-47EF-8E98-AF7532DD637FQ43555696-93378F77-4896-407A-A625-E39B10544AFFQ43578469-04744705-6D71-4E03-A4BD-3339A3E5F63EQ52722785-C9B7DBD3-7C4B-4696-9E50-8B88BDF6DFDBQ53755710-DD9A108C-6B6D-457D-8AAE-777AC0EAC98CQ58579081-8FB8272C-4B3C-44DD-BB8E-94698D9ECA53Q88581487-5D25408C-1AD4-49B6-B917-693F8D33EC86Q92191312-FC24F216-BFAA-4A08-8237-9C6A6F112940
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Nathan R. Wall
@ast
Nathan R. Wall
@en
Nathan R. Wall
@es
Nathan R. Wall
@nl
Nathan R. Wall
@sl
type
label
Nathan R. Wall
@ast
Nathan R. Wall
@en
Nathan R. Wall
@es
Nathan R. Wall
@nl
Nathan R. Wall
@sl
altLabel
NR Wall N Wall
@en
prefLabel
Nathan R. Wall
@ast
Nathan R. Wall
@en
Nathan R. Wall
@es
Nathan R. Wall
@nl
Nathan R. Wall
@sl
P1053
H-7368-2015
P106
P1153
7003411560
P2038
Nathan_Wall
P21
P31
P3829
P496
0000-0002-3235-4386